Head and neck cancer patients undergoing major surgery Head and neck cancer,
Conditions
Interventions
mune,
an immune-
enhancing diet ,Hospital prepared blenderized diet,
regularly used in hospitalized patient
mune ,Hospital blenderized diet
Sponsors
None
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Head and neck cancer patients undergoing major surgery Age 18-75 years
Exclusion criteria
Exclusion criteria: Previous head and neck surgery Previous head and neck radiation Poor liver function(Total bilirubin > 3.5 mg/dl) Poor renal function (Serum creatinine > 2.5 mg/dl) Underlying immunodeficiency or taking immunosuppressive drug Allergy to arginine, glutamine,fish oil, or soy protein Pregnancy or breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum albumin, prealbumin, transferrin, total lymphocyte count 1st, 7th, and 14th days after the operation Albumin (g/dl), Prealbumin (mg/dl), Transferrin (mg/dl), Total lymphocyte count (cells/mm2) | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical site infection rate, length of hospital stay 1 month, until discharge date percent of patients with surgical site infection, days of hospitalization | — |
Countries
Thailand
Contacts
Public ContactPichit Sittitrai
Department of Otolaryngology, Faculty of Medicine, Chiang Mai University
Outcome results
None listed